202 related articles for article (PubMed ID: 10662591)
1. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
[TBL] [Abstract][Full Text] [Related]
2. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
3. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
7. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono S; Chou MJ; Lee CS; Shih C
Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
[TBL] [Abstract][Full Text] [Related]
8. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
11. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
Teramoto T; Satonaka K; Kitazawa S; Fujimori T; Hayashi K; Maeda S
Cancer Res; 1994 Jan; 54(1):231-5. PubMed ID: 8261444
[TBL] [Abstract][Full Text] [Related]
12. State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses.
Rivkina MB; Cullen JM; Robinson WS; Marion PL
Cancer Res; 1994 Oct; 54(20):5430-7. PubMed ID: 7923176
[TBL] [Abstract][Full Text] [Related]
13. [Study on p53 gene mutation in hepatocellular carcinoma patients in China].
Kang G; Fang Z; Volkmann M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):163-5. PubMed ID: 11436649
[TBL] [Abstract][Full Text] [Related]
14. p53 gene mutation spectrum in hepatocellular carcinoma.
Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
[TBL] [Abstract][Full Text] [Related]
15. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
[TBL] [Abstract][Full Text] [Related]
17. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
[TBL] [Abstract][Full Text] [Related]
18. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
Qin L; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
[TBL] [Abstract][Full Text] [Related]
19. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between mutation of tumor suppressor gene p53 and development of hepatocellular carcinoma].
Zhu MH
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):245-7. PubMed ID: 7909744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]